Sponsor:
Weill Medical College of Cornell University
Code:
NCT05134779
Conditions
Breast Cancer
Eligibility Criteria
Sex: Female
Age: 18 - 70+
Healthy Volunteers: Not accepted
Interventions
Live Biobank
Brief summary:
Conditions
Breast Cancer
Study ID
NCT05134779
Start date
Jan 12, 2022
Status verified date
Dec, 2025
Completion date
Dec 31, 2028
Anticipated
Primary completion date
Dec 31, 2027
Anticipated
Eligibility Criteria
Sex: Female
Age: 18 - 70+
Healthy Volunteers: Not accepted
Enrollment
400 participants
Anticipated
Arms
Cohort 1
Interventions
Live Biobank
Primary outcome measure
Central contacts
Locations
Brooklyn Methodist Hospital - NewYork Presbyterian
Recruiting
New York, New York, United States, 11215
Contacts
Principal Investigator:
Hani Ashamalla, M.D.
New York Presbyterian Hospital - Queens
Recruiting
New York, New York, United States, 11355
Contacts
Hina Ali, M.D.
hia4002@med.cornell.eduPrincipal Investigator:
Silvia Formenti, M.D.
Sponsor
Weill Medical College of Cornell University
Last update posted
Dec 18, 2025
Last verified
Dec, 2025
Trial information was received from ClinicalTrials.gov and was last updated on 2026-09-10. This information was provided to ClinicalTrials.gov by Weill Medical College of Cornell University on 2025-12-18.